MedPath

The benefits of early inotropic administration compared to refractory phase inotropic administration in pediatric patients with septic shock

Phase 3
Completed
Conditions
Improvement in the outcome of pediatric patients with septic shock by early administration of inotropic
Infections and Infestations
Registration Number
ISRCTN40192699
Lead Sponsor
dayana University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
13
Inclusion Criteria

1. Pediatric patients diagnosed with septic shock and presenting to the pediatric emergency department of RS Prof Ngoerah between December 2019 and December 2020
2. Pediatric patients whose parents agree to sign the informed consent

Exclusion Criteria

1. Pediatric patients with congenital diseases, such as congenital heart disease
2. Undergoing therapy for renal diseases
3. History of prematurity
4. Fluid resuscitation has been done in other healthcare facilities

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ferritin levels in blood samples measured using a ferritin test at 1, 6, and 24 hours following the administration of epinephrine
Secondary Outcome Measures
NameTimeMethod
<br> Levels in blood samples at 1, 6, and 24 hours following administration of epinephrine:<br> 1. Leukocytes measured using a white blood cell count<br> 2. C-Reactive Protein (CRP) measured using a CRP test<br> 3. Troponin-I measured using a troponin test<br> 4. Lactate measured using a lactic acid test<br> 5. Oxygen saturation measured using a pulse oximeter<br>
© Copyright 2025. All Rights Reserved by MedPath